HomeTagsFood

food

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

The Profit Growth Strategy Behind Kimly’s 1H FY2026

5 Strategic Takeaways from Kimly’s 1H FY2026 Results To many Singaporeans, Kimly is the ubiquitous...
SGX-LISTED COMPANIES

How Envictus Offset Middle East Headwinds In 1H FY2026

Chickens Hunker Down as Dairy Takes Flight How does a geopolitical flare-up in the Persian...
SGX-LISTED COMPANIES

Sales Are Up, But Where’s The Cash? China Kangda Food FY2025

4 Surprising Takeaways from China Kangda’s 2025 Financials China Kangda Food Company Limited occupies a...
SGX-LISTED COMPANIES

Why OTS Holdings Is Betting Big Despite A Swing To The Red In 1H 2026

A Tale of Two Semesters In the volatile food manufacturing sector, a single year can...
SGX-LISTED COMPANIES

Thai Beverage Reports Mixed FY25

4 Surprising Takeaways From ThaiBev's FY2025 Financials Introduction: At first glance, Thai Beverage's financial year 2025...
SGX-LISTED COMPANIES

United Food Holdings Q2 FY2026: Delisting Imminent, Will Shareholders Get An Exit?

4 Shocking Red Flags Hidden in a Single Financial Report Sometimes, buried within the tables...
SGX-LISTED COMPANIES

Sakae Holdings: Financial Results 30 June 2025

Sakae Holdings LTD navigated a challenging F&B landscape, facing increased operating costs and cautious...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...